Our study showed that Luminal A and TNBC breast cancer subtypes may predict a lower risk of lymph node metastases when compared to luminal B and HER2 cancers, which was consistent with Gangi's study and Mazouni's study [16, 18]. The gene discussed is ERBB2; the disease is breast cancer.